Osteopore Limited announced promotion of Dr. Lim Jing to the role of Chief Executive Officer (CEO), effective 18 July 2023. Dr. Lim joined Osteopore in 2014 and since 2018 has held the position of Chief Technology Officer (CTO). In 2022, Dr. Lim was appointed Chief Operating Officer (COO).

A PhD graduate from Singapore's Nanyang Technology University, Dr. Lim played a key role in the Company reaching key regulatory and quality milestones including compliance with the European Union's Medical Device Regulation (MDR). Dr. Lim also spearheaded a successful AUD19 million project with the National Dental Centre and A*Star. In 2022, Dr. Lim succeeds Mr. Goh as CEO as part of a planned succession that will see Mr. Goh move into the newly created role of Global Marketing Director to drive Osteopore's commercialization objectives.

With this new role, Osteopore will be able to leverage Mr. Goh's deep experience in the medical device sector to grow market adoption and revenue.